International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Chronic Obstructive Pulmonary Disease (COPD)

Primary Care Respiratory Journal

Volumn 15, Issue 1, 2006, Pages 48-57

  Bellamy, David ^a   Bouchard, Jacques ^b   Henrichsen, Svein ^c   Johansson, Gunnar ^d   Langhammer, Arnulf ^e   Reid, Jim ^f   Van Weel, Chris ^c   Buist, Sonia ^g  

^a James Fisher Medical Centre   (United Kingdom)

^b ST JOSEPH S HOSPITAL   (Canada)

^c L11 Familiehelsesenter ^*  (Netherlands)

^d Uppsala Science Park   (Sweden)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Classification; COPD; General practice; Guideline; Management; Primary care; Spirometry; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GLUCOCORTICOID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; MEDICAL SOCIETY; OXYGEN THERAPY; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PULMONARY REHABILITATION; REVIEW; RISK FACTOR; SMOKING CESSATION; SPIROMETRY;

EID: 31544465514     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.1016/j.pcrj.2005.11.003     Document Type: Article

References (34)

1. International Primary Care Airways Group (IPAG). Chronic airways diseases: a guide for primary care physicians. Available at the URL: http://www.ipagguide.org/IPAG_copyright_draft.pdf.
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. National Institutes of Health, National Heart, Lung, and Blood Institute; April 2001 (Updated 2004). Available at URL: http://www.goldcopd.com.
3. M.L. Levy, M. Fletcher, D.B. Price, T. Hausen, R.J. Halbert, and B.P. Yawn International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care Prim Care Resp J 15 1 2006 20 34
4. T. van der Molen, A. Østrem, B. Stallberg, M. Stubbe Østergaard, and R.B. Singh International Primary Care Respiratory Group (IPCRG) Guidelines: Management of asthma Prim Care Resp J 15 1 2006 35 47
5. D. Price, C. Bond, J. Bouchard, R. Costa, J. Keenan, M. Levy, M. Orru, D. Ryan, S. Walker, and M. Watson International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis Prim Care Resp J 15 1 2006 59 71
6. Royal College of General Practitioners. The development and implementation of clinical guidelines. Report of the clinical guidelines working group. London, 1995, RCGP.
7. N.R. Anthonisen, J.E. Connett, and J.P. Kiley Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study JAMA 272 1994 1497 1505
8. J. Britton, and A. Knox Helping people to stop smoking: the new smoking cessation guidelines Thorax 54 1999 1 2
9. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives A clinical practice guideline for treating tobacco use and dependence JAMA 28 2000 3244 3254
10. American Medical Association Guidelines for the diagnosis and treatment of nicotine dependence: how to help patients stop smoking 1994 American Medical Association Washington DC
11. K.R. Smith National burden of disease in India from indoor pollution Proc Natl Acad Sci USA 97 2000 13286 13293
12. L.M. Janelli, Y.K. Scherer, and L.E. Schmeider Can a pulmonary health teaching program alter patients' ability to cope with COPD? Rehabil Nurs 16 1991 199 202
13. T. Ashikaga, P.M. Vacek, and S.O. Lewis Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease J Rehabil 46 1980 23 27
14. M.J. Berry, W.J. Rejeski, and N.E. Adair Exercise rehabilitation and chronic obstructive pulmonary disease stage Am J Respir Crit Care Med 160 1999 1248 1253
15. M. Behnke, C. Taube, and D. Kirsten Home - based exercise is capable of preserving hospital - based improvements in severe chronic obstructive pulmonary disease Respir Med 94 2000 1184 1191
16. R.H. Green, S.J. Singh, and J. Williams A randomised controlled trial of four weeks versu seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease Thorax 56 2001 143 145
17. A.L. Ries, R.M. Kaplan, and R. Myers Maintenance after pulmonary rehabilitation in chronic lung disease: a randomised trial Am J Crit Care Respir Med. 167 2003 880 888
18. Nocturnal Oxygen Therapy Group Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial Ann Intern Med 93 1980 391 398
19. Report of the Medical Research Council Working Party Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Lancet 1 1981 681 686
20. A.S. Vathenen, J.R. Britton, and P. Ebden High dose inhaled albuerol in severe chronic airflow limitation Am Rev Resp Dis 138 1988 850 855
21. N.J. Gross, T.L. Petty, and M. Friedman Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three -center study Am Rev Respir Dis. 139 1989 1188 1191
22. COMBIVENT Inhalation Aerosol Study Hgroup In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial Chest 105 1994 1411 1419
23. D.A. Mahler, J.F. Donohue, and R.A. Barbee Efficacy of salmeterol xinofoate in the treatment of COPD Chest 115 1999 957 965
24. VinckenW, J.A. van Noord, and A.P. Greefhorst Improved health outcomes in patients with COPD during 1 years treatment with tiotropium Eur Respir J 19 2002 209 216
25. P.S. Burge, P.M. Calverley, and P.W. Jones Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303
26. P.G. Gibson, J.H. Wiodarczyk, and A.J. Wilson Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital J Qual Clin Pract 18 1998 125 133
27. R. Wilson The role of infection in COPD Chest 113 1998 242S 248S
28. H.R. Anderson, C. Spix, and S. Medina Air pollution and daily admissions of chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project Eur RESPIR j 10 1997 1064 1071
29. P. Lloberes, L. Ramis, and J.M. Montserrat Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease Eur Respir J 1 1988 536 539
30. L. Davies, R.M. Angus, and P.M. Calverley Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease Lancet 354 1999 456 460
31. N.R. Anthonisen, J. Manfreda, and C.P. Warren Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204
32. R.A. Stockley, C. O'Brien, and A. Pye Relationship of sputum colour to nature and oupatient management of acute exacerbations of COPD Chest 117 2000 1838 1845
33. T. Lancaster, L. Steaad, and C. Silagy Effectiveness of interventions to help people stop smoking: findings from the Cochran Library BMJ 321 2000 355 358
34. M.C. Fiore, S.S. Smith, and D.E. Jorenby The effectiveness of the nicotine patch for smoking cessation. A meta-analysis JAMA 271 1994 1940 1947